Financings in Brief: Orthofix
This article was originally published in The Gray Sheet
Executive Summary
Orthofix: Announces its intent to expand by 36% its holding in Novamedix, developer of the A-V Impulse System foot-pump for prevention of deep vein thrombosis. Orthofix' acquisition of the additional interest, expected to take place in August, will bring its stake in Novamedix to 80%. The announcement coincides with a decision in the London Patents County Court that NDM(UK) Ltd., marketer of the Act One Foot Pump, had infringed a Novamedix patent and had committed "passing off" by using abstracts of clinical studies in promotional literature for Act One without indicating that the studies related to the A-V Impulse System...